Skip to main content

Table 1 Demographic data for patients treated with pemetrexed plus platinum (n = 53).

From: Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients

Patient criteria N (%)
Patient number 53
Median age (range) 52 (34--68)
Sex  
   Male 39 (73.6)
   Female 14 (26.4)
Weight, kg: mean ± SD (range) 69 ± 10.1 (40--96)
Stage  
   IIIB 15 (28.3)
   IV 38 (71.7)
ECOG Performance status  
   0 4 (7.5)
   1 36 (67.9)
   2 13 (24.5)
Histology  
   Adenocarcinoma 31 (58.5)
   Alveolar carcinoma 6 (11.3)
   Squamous carcinoma 14 (26.4)
   Large cell carcinoma 1(1.9)
   Mixed carcinoma 1(1.9)
No. chemotheraphy line  
   Second line 34 (64.2)
   Third line 15 (28.3)
   Fourth lines 4 (7.5)